Cellectis SA (CLLS)
3.00
-0.04
(-1.31%)
USD |
NASDAQ |
May 17, 16:00
3.00
0.00 (0.00%)
After-Hours: 20:00
Cellectis Accounts Receivable (Quarterly): 0.569M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.569M |
September 30, 2023 | 0.393M |
June 30, 2023 | 0.422M |
March 31, 2023 | 1.12M |
December 31, 2022 | 0.772M |
September 30, 2022 | 0.802M |
June 30, 2022 | 2.602M |
March 31, 2022 | 21.84M |
December 31, 2021 | 20.36M |
September 30, 2021 | 0.348M |
June 30, 2021 | 3.877M |
March 31, 2021 | 6.386M |
December 31, 2020 | 5.171M |
September 30, 2020 | 4.036M |
June 30, 2020 | 3.976M |
March 31, 2020 | 3.004M |
December 31, 2019 | 2.959M |
September 30, 2019 | 8.038M |
June 30, 2019 | 2.99M |
March 31, 2019 | 2.801M |
December 31, 2018 | 2.971M |
September 30, 2018 | 1.813M |
June 30, 2018 | 2.486M |
March 31, 2018 | 3.419M |
December 31, 2017 | 2.753M |
Date | Value |
---|---|
September 30, 2017 | 2.897M |
June 30, 2017 | 4.972M |
March 31, 2017 | 5.380M |
December 31, 2016 | 3.627M |
September 30, 2016 | 12.77M |
June 30, 2016 | 15.37M |
March 31, 2016 | 6.357M |
December 31, 2015 | 6.598M |
September 30, 2015 | 1.893M |
June 30, 2015 | 3.806M |
March 31, 2015 | |
December 31, 2014 | 7.151M |
June 30, 2014 | 3.186M |
December 31, 2013 | 3.712M |
June 30, 2013 | 18.11M |
June 30, 2013 | 18.11M |
December 31, 2012 | 8.069M |
June 30, 2012 | 18.28M |
December 31, 2011 | 14.88M |
December 31, 2010 | 3.313M |
June 30, 2010 | 1.484M |
June 30, 2010 | 1.484M |
December 31, 2009 | 2.533M |
June 30, 2009 | 1.219M |
June 30, 2009 | 1.219M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
0.348M
Minimum
Sep 2021
21.84M
Maximum
Mar 2022
4.719M
Average
2.99M
Median
Jun 2019
Accounts Receivable (Quarterly) Benchmarks
DBV Technologies SA | -- |
Biophytis SA | 0.3283M |
Genfit SA | 20.48M |
Edap TMS SA | 19.00M |
Adaptimmune Therapeutics PLC | 8.404M |